AngioInsight
Value Proposition
AngioInsight improves clinical outcomes through patient-specific diagnosis and management of coronary artery disease, and reduces the cost of care through appropriate allocation of medical resources.
Competitive Advantage
Pilot work conducted includes exploration of a proof-of-concept version of AngioInsight, exploring high quality, minimal disease, and limited artifact angiogram videos to train the algorithm. A promising number of correct identifications occurred.
More work will be conducted to determine the accurate identification of more significant and complex blockages.
Unique Features
Real-time, quantitative assessment of stenosis
Non-invasive measure of blood flow across stenosis
Licensing Information
AngioInsight in 2018
Principal Investigators
Brahmajee Nallamothu, PhD
Kayvan Najarian, PhD
C. Alberto Figueroa, PhD
Intellectual Property
Invention Disclosure # 6787, 6864, 7470, 2019-464
Patent Granted # US9962124B2
Solution Sheet
Download Solution Sheet (PDF)
Image courtesy of project team
Over 2.2 million patients with coronary artery disease (CAD) undergo angiography to evaluate severity of blood vessel blockage (i.e., stenosis). For nearly all of those of patients, clinical treatment decisions are based on subjective physician visual assessment of angiograms. AngioInsight augments patient-specific treatment decisions and optimized allocation of healthcare resources for CAD.
Contact AngioInsight for more information about investment and partnership opportunities.
Funding History
$767,995 in non-dilutive funding
2015 $102,995 MTRAC
2019 $300,000 Angel Investor
2020 $200,000 Angel Investor
2020 $20,000 SPARK Business Accelerator Fund Grant
2021 $70,000 Gopher Angels
2021 $25,000 Dakota Venture Group
2021 $50,000 Angel Investor
Substantial additional departmental, school and center based support
Funding Organizations
